Microsoft, Elanco, Monster Beverage, and Jazz Pharmaceuticals were cited in thematic investing as examples of diverse winners in the pharmaceuticals segment.
2 reports, 1 independent
Updated Aug 3
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Microsoft, Elanco, Monster Beverage, and Jazz Pharmaceuticals were cited in thematic investing as examples of diverse winners in the pharmaceuticals segment.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Jazz Pharmaceuticals
Irish tax-registered pharmaceutical corporation
Nothing else this week.
-
Monster Beverage
American beverage company
-
Microsoft
American multinational technology corporation
- Major AI companies, including Anthropic, Google, Microsoft, and OpenAI, have implemented shared protocols and documented changes to AI crawler identities.
- Microsoft's Azure cloud division grew 48%, Intel plunged on weak guidance, while the Bank of Japan signaled tightening and West Texas crude exceeded $100.
-
Elanco
American healthcare company
Nothing else this week.
Related events
- Monster Beverage and Microsoft were cited as diverse winners in the banks segment in thematic investing on July 22, 2025, alongside Annaly Capital Management and Citigroup.
- Microsoft, Booz Allen Hamilton, ManpowerGroup, and Robert Half were mentioned in the context of thematic investing and their presence in the professional services segment.
- Citigroup and Paychex were analyzed as investment opportunities on July 28, 2025.
- Microsoft and ASML Holding N.V. are noted as prominent technology stocks.
- Market commentary highlights Apple's valuation surpassing Microsoft and Dell, alongside Fisher Investments promoting a new investment guide.
Coverage
Newest first; wire copies grouped- StockStoryWhat To Expect From Elanco’s (ELAN) Q2 Earnings Animal health company Elanco (NYSE:ELAN) will be reporting results this Thursday before market open. Here’s what to expect. Elanco beat analysts’ reven